Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Novozymes Opens Hyaluronic Acid Plant in Tianjin

publication date: May 16, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Novozymes Biopharma, the pharmaceutical subsidiary of Novozymes A/S, a Swedish maker of industrial enzymes, has begun selling hyaluronic acid that is made at its new Tianjin facility. Novozymes’ HA product is manufactured via a Bacillus-based process, while conventionally produced HA is derived from rooster combs or strains of Streptococcus bacteria. In comparison to its competitors’ HA, Novozymes says its HA is less prone to impurities or viral contamination. More details....

Stock Symbols: (NSDQ OMX: Copenhagen: NZYM B)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners